Aspiro Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ASPIRO, and what generic and branded alternatives to ASPIRO drugs are available?
ASPIRO has fifteen approved drugs.
Drugs and US Patents for Aspiro
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Aspiro | SUGAMMADEX SODIUM | sugammadex sodium | SOLUTION;INTRAVENOUS | 214337-002 | Jun 9, 2023 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Aspiro | VORICONAZOLE | voriconazole | INJECTABLE;INTRAVENOUS | 218533-001 | Apr 3, 2024 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Aspiro | KETOROLAC TROMETHAMINE | ketorolac tromethamine | INJECTABLE;INJECTION | 217166-002 | Jun 20, 2023 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Aspiro | SUGAMMADEX SODIUM | sugammadex sodium | SOLUTION;INTRAVENOUS | 214337-001 | Jun 9, 2023 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Aspiro | BUPIVACAINE HYDROCHLORIDE | bupivacaine hydrochloride | INJECTABLE;INJECTION | 217821-002 | Mar 27, 2024 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Aspiro | DAPTOMYCIN | daptomycin | POWDER;INTRAVENOUS | 216413-001 | Sep 23, 2022 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.